Retatrutide is a powerful triple-action peptide studied for fat loss, type 2 diabetes, and liver health.
How It Works
It activates GLP-1, GIP, and glucagon receptors.
This triple hormone effect reduces appetite, burns fat, and improves blood sugar.
Mechanism of Action
Boosts insulin, suppresses glucagon, and increases energy use.
Improves metabolic markers and reduces liver fat.
Benefits
Promotes deep fat loss and improved body composition
Enhances blood sugar control in diabetics
Reduces liver fat and supports metabolic health
May lower cardiovascular risk factors
Usage
Used in clinical trials for obesity, diabetes, and NAFLD.
Injected subcutaneously once per week under medical guidance.
Recommended Dosage
Start with 1–2mg per week to assess tolerance
Gradually increase to a maximum of 12mg weekly
Doses above 12mg are still experimental and not widely used
Always follow a medically supervised titration plan
Safety and Considerations
Common side effects include nausea, fatigue, and mild digestive issues.
Only available through clinical trials at this time.
Conclusion
Retatrutide shows incredible promise as a next-gen weight loss and metabolic health peptide.
Use is currently experimental but highly anticipated.